Cecile D. Lahiri
YOU?
Author Swipe
View article: Interleukin-6 is associated with high-risk plaque on coronary computed tomography angiography in asymptomatic women
Interleukin-6 is associated with high-risk plaque on coronary computed tomography angiography in asymptomatic women Open
View article: Integration of Longitudinal Metabolome and Lipidome Changes Associated With Weight Gain in Women With HIV After Integrase Strand Transfer Inhibitor Initiation – A Pilot Study
Integration of Longitudinal Metabolome and Lipidome Changes Associated With Weight Gain in Women With HIV After Integrase Strand Transfer Inhibitor Initiation – A Pilot Study Open
View article: The impact of childhood maltreatment, HIV status, and their interaction on mental health outcomes and markers of systemic inflammation in women
The impact of childhood maltreatment, HIV status, and their interaction on mental health outcomes and markers of systemic inflammation in women Open
View article: 332 The link between sarcopenia and frailty in persons with HIV on integrase strand-transfer inhibitors (INSTIs)
332 The link between sarcopenia and frailty in persons with HIV on integrase strand-transfer inhibitors (INSTIs) Open
Objectives/Goals: To assess the association between integrase strand-transfer inhibitor (INSTI) use and sarcopenia, pre-frailty, and frailty in people living with HIV (PLWH) compared to non-INSTI users and HIV-seronegative controls, focusi…
View article: Aberrant DNA methylation of genes regulating CD4+ T cell HIV‐1 reservoir in women with HIV
Aberrant DNA methylation of genes regulating CD4+ T cell HIV‐1 reservoir in women with HIV Open
Background The HIV‐1 reservoir in CD4+ T cells (HR CD4 ) pose a major challenge to curing HIV, with many of its mechanisms still unclear. HIV‐1 DNA integration and immune responses may alter the host's epigenetic landscape, potentially sil…
View article: Posttraumatic Stress Disorder Is Associated With Endothelial Dysfunction in Women With HIV
Posttraumatic Stress Disorder Is Associated With Endothelial Dysfunction in Women With HIV Open
PTSD is independently associated with ED in WWH. Whether treatment for PTSD improves ED and CVD in WWH needs further study.
View article: Impact of switching to a dolutegravir‐based regimen on body weight changes: insights from West African adult HIV cohorts
Impact of switching to a dolutegravir‐based regimen on body weight changes: insights from West African adult HIV cohorts Open
Introduction Adverse metabolic effects related to dolutegravir (DTG) are increasingly reported as countries are adopting DTG‐based regimens as first‐line antiretroviral therapy (ART), but there is limited data from sub‐Saharan Africa. We e…
View article: The role of the HIV-1 gut reservoir in driving early cardiovascular events in people living with HIV
The role of the HIV-1 gut reservoir in driving early cardiovascular events in people living with HIV Open
People with HIV (PWH), even when well-controlled on antiretroviral therapy (ART), are at an increased risk for cardiovascular disease (CVD) and CVD events including sudden cardiac death and acute myocardial infarction (MI). While PWH may a…
View article: Consequences of low-level viremia among women with HIV in the United States
Consequences of low-level viremia among women with HIV in the United States Open
Objective: Investigate the outcomes of women with HIV (WWH) with low-level viremia (LLV). Design: The prevalence of LLV and potential clinical sequelae, such as virologic failure and non-AIDS comorbidity (NACM) development, are poorly char…
View article: Epigenome-wide characterization reveals aberrant DNA methylation of host genes regulating CD4+ T cell HIV-1 reservoir size in women with HIV
Epigenome-wide characterization reveals aberrant DNA methylation of host genes regulating CD4+ T cell HIV-1 reservoir size in women with HIV Open
The underlying mechanism of the HIV-1 reservoir, a major barrier to an HIV cure, is largely unknown. The integration of HIV-1 DNA and immune defense mechanisms can disrupt the host epigenetic landscape, potentially silencing HIV-1 replicat…
View article: The impact of diabetes mellitus on HIV virologic control: results of the MACS/WIHS combined cohort study
The impact of diabetes mellitus on HIV virologic control: results of the MACS/WIHS combined cohort study Open
Objective: Diabetes mellitus (DM) is associated with lower antiretroviral (ART) drug exposure among persons with HIV (PWH) compared to PWH without DM. The association between DM and virologic control in PWH, however, remains unknown. Metho…
View article: Supplemental Figure 5 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 5 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Supplemental Figure 5: Effect of HPV16 qPCR copynumber(CN) per cell on HPV16 infections.
View article: Data from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Data from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Background:Effective screening for oropharyngeal cancer is lacking. Four oncogenic HPV clearance definitions were explored to understand long-term natural history for persistent oncogenic oral HPV (oncHPV), the precursor of oropharyngeal c…
View article: Supplemental Figure 5 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 5 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Supplemental Figure 5: Effect of HPV16 qPCR copynumber(CN) per cell on HPV16 infections.
View article: Supplemental Table 2 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Table 2 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Supplemental Table 2: Multivariate predictors of clearance, across the four different clearance definitions evaluated in this study.
View article: Supplemental Figure 7 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 7 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Supplemental Figure 7: Effect of HPV type (16 vs non16 oncogenic HPV type) on prevalent (SF7a) incident (SF7b) infections.
View article: Supplemental Table 2 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Table 2 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Supplemental Table 2: Multivariate predictors of clearance, across the four different clearance definitions evaluated in this study.
View article: Supplemental Figure 4 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 4 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Supplemental Figure 4: Effect of sex on prevalent (SF4a) incident (SF4b) infections.
View article: Supplemental Figure 6 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 6 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Supplemental Figure 6: Effect of HIV and CD4 on prevalent (SF6a) incident (SF6b) infections.
View article: Supplemental Table 1 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Table 1 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Supplemental Table 1: Proportion of 1833 subjects screened who have oncogenic oral HPV DNA and cancer characteristics.
View article: Data from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Data from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Background:Effective screening for oropharyngeal cancer is lacking. Four oncogenic HPV clearance definitions were explored to understand long-term natural history for persistent oncogenic oral HPV (oncHPV), the precursor of oropharyngeal c…
View article: Supplemental Figure 3 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 3 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Supplemental Figure 3: Effect of age on prevalent (SF3a) incident (SF3b) infections.
View article: Supplemental Figure 4 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 4 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Supplemental Figure 4: Effect of sex on prevalent (SF4a) incident (SF4b) infections.
View article: Supplemental Figure 2 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 2 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Supplemental Figure 2: Clearance of prevalent (panel A) and incident (panel B) oral HPV16 infections over 10 years
View article: Supplemental Figure 1 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 1 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Supplemental Figure 1: Flowchart of the 1833 MACS and WIHS participants in the POPS, how many had oncogenic oral HPV DNA, and how many had additional follow-up of uncleared infections as part of the MOUTH study.
View article: Supplemental Figure 6 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 6 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Supplemental Figure 6: Effect of HIV and CD4 on prevalent (SF6a) incident (SF6b) infections.
View article: Supplemental Figure 7 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 7 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Supplemental Figure 7: Effect of HPV type (16 vs non16 oncogenic HPV type) on prevalent (SF7a) incident (SF7b) infections.
View article: Supplemental Figure 1 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 1 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Supplemental Figure 1: Flowchart of the 1833 MACS and WIHS participants in the POPS, how many had oncogenic oral HPV DNA, and how many had additional follow-up of uncleared infections as part of the MOUTH study.
View article: Supplemental Figure 3 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 3 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Supplemental Figure 3: Effect of age on prevalent (SF3a) incident (SF3b) infections.
View article: Supplemental Table 1 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Table 1 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Supplemental Table 1: Proportion of 1833 subjects screened who have oncogenic oral HPV DNA and cancer characteristics.